COVID-19 Policy Update WEDNESDAY 2/24 TOP THREE Johnson & Johnson Vaccine: FDA review confirms safety and efficacy of the single-shot vaccine. It was found to be: 66.9% effective against moderate to severe/critical COVID-19 cases 14 days after vaccination, and 66.1% effective after 28 days.
COVID-19 Policy Update #206
COVID-19 Policy Update #206
COVID-19 Policy Update #206
COVID-19 Policy Update WEDNESDAY 2/24 TOP THREE Johnson & Johnson Vaccine: FDA review confirms safety and efficacy of the single-shot vaccine. It was found to be: 66.9% effective against moderate to severe/critical COVID-19 cases 14 days after vaccination, and 66.1% effective after 28 days.